About 260 Mg-43.4 Ml Paclitaxel Injection
Jump on exceptional clearance offers and unlock grandiose savings with the highly sought-after 260 Mg-43.4 Ml Paclitaxel Injection. This sterile, pyrogen-free solution is expertly formulated for intravenous use, targeting a range of cancers-including ovarian, breast, and non-small cell lung. Packaged in a single glass vial, its potent 260 mg dose is soluble in cremophor EL and dehydrated alcohol and maintains a clear to slightly yellowish viscous appearance. Prescribed only, handle with caution as cytotoxic. Store at 20C to 25C for optimum efficacy and shelf life of up to 24 months. Distributed, exported, and supplied directly from India.
Directions, Application, and Features
For maximum efficacy, 260 Mg-43.4 Ml Paclitaxel Injection must be administered intravenously under medical supervision. Applied exclusively via IV route, this antineoplastic agent is designed for single use to ensure sterile delivery and patient safety. Notable features include its pyrogen-free formulation, cytotoxic nature, and compatibility with cremophor EL and dehydrated alcohol solvents, resulting in a clear or slightly yellowish viscous solution. Adhere strictly to healthcare protocols when handling and disposing of the product.
Certifications, Samples, and Export Markets
Order completion for 260 Mg-43.4 Ml Paclitaxel Injection adheres to strict regulatory compliance and transparent expenditure. Quotations are swiftly provided for potential buyers, and samples may be available for assessment upon request. This product holds regulatory approval (Rx only) and is widely distributed across major export markets, notably from India. All certifications are maintained as per industry standards, ensuring that global deliveries meet precise medical and safety requirements.
FAQ's of 260 Mg-43.4 Ml Paclitaxel Injection:
Q: How should 260 Mg-43.4 Ml Paclitaxel Injection be administered for cancer treatment?
A: Paclitaxel Injection must be given intravenously by a qualified healthcare professional in a clinical setting to ensure safe and effective delivery.
Q: What cancers are treated with this sought-after Paclitaxel Injection?
A: This injection is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and various other malignancies as prescribed by an oncologist.
Q: When is the ideal time to use Paclitaxel 260 mg Injection during therapy?
A: Utilization depends on your cancer treatment schedule and should follow an oncologist's recommendations, usually following specific cycles and after comprehensive evaluation.
Q: Where can I purchase or export 260 Mg-43.4 Ml Paclitaxel Injection?
A: The product can be obtained through authorized distributors, exporters, suppliers, or traders, primarily marketed and shipped from India, with availability subject to regulatory approvals.
Q: What is the handling and storage process for this cytotoxic injection?
A: Handle with extra caution due to its cytotoxic warning. The injection should be stored between 20C to 25C, with permitted temperature excursions; always follow manufacturer instructions for safety.
Q: What are the main benefits of choosing this Grandiose Injection?
A: This formulation offers reliable antineoplastic action, single-use sterility, and substantial shelf life, making it a sought-after choice for clinicians seeking effective chemotherapy options.